Gene: RSBN1
Official Full Name: round spermatid basic protein 1provided by HGNC
Gene Summary: Predicted to enable histone H4K20 demethylase activity and metal ion binding activity. Predicted to be involved in chromatin remodeling. Predicted to be located in endoplasmic reticulum. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO21571 | RSBN1 Knockout cell line (HeLa) | Human | RSBN1 | 1:3~1:6 | Negative | Online Inquiry |
KO21572 | RSBN1 Knockout cell line (HCT 116) | Human | RSBN1 | 1:2~1:4 | Negative | Online Inquiry |
KO21573 | RSBN1 Knockout cell line (HEK293) | Human | RSBN1 | 1:3~1:6 | Negative | Online Inquiry |
KO21574 | RSBN1 Knockout cell line (A549) | Human | RSBN1 | 1:3~1:4 | Negative | Online Inquiry |
RSBN1 Gene Knockout Cell Lines are genetically modified cell lines specifically designed for the functional analysis of the RSBN1 gene, known to play a critical role in various biological processes, including cell signaling and development. These cell lines have been created using precise gene editing techniques, such as CRISPR/Cas9, to ensure that the RSBN1 gene is completely inactivated, allowing researchers to study the resulting phenotypic changes in cellular behavior and function.
The key mechanism of action behind these knockout cell lines lies in the targeted disruption of the RSBN1 gene, which not only aids in elucidating the gene's function but also serves as a valuable tool for investigating its potential implications in disease mechanisms, such as cancers or developmental disorders. In both research and clinical settings, these cell lines can facilitate high-throughput screening and drug discovery efforts by providing a platform to assess the cellular responses to various therapeutic agents in the absence of RSBN1 function.
What sets RSBN1 Gene Knockout Cell Lines apart from alternative models is their specificity and reliability. Traditional methods may not provide the same level of accuracy in studying gene function, while these knockout lines offer a clear advantage through their precise genomic modifications. Moreover, these cell lines are characterized by robust growth and adaptability, allowing researchers to perform longitudinal studies with consistent data.
For researchers and clinicians focused on understanding the complexities of gene function in both normal and pathological states, RSBN1 Gene Knockout Cell Lines represent a foundational tool that can lead to transformative insights and novel therapeutic strategies. Leveraging our extensive experience in genetic engineering and cell line development, our company is committed to providing high-quality biological products that empower the scientific community in their quest for discovery and innovation.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.